P/B
6,4
Journey Medical
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
$204.6M
Market Cap • 9/22/2026
2014
(12 years)
Founded
2021
(5 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
3
P/EBITDA
156,6
P/OCF
—
P/FCF
—
P/E
—
BVPS
1,2
EPS
—
Market Cap
Market Cap
204,6M
EV
204,5M
EV/Revenue
3
EV/EBITDA
156,5
EV/EBIT
-68
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-6,3%
Total Yield
-6,3%
Payout
0%
Retained Earnings
-101M
Profitability
Gross Margin
65,5%
EBITDA Margin
1,9%
EBIT Margin
—
Net Margin
—
D&A/EBITDA
323,2%
R&D/Revenue
0,7%
Capex/Revenue
0%
Capex/D&A
0%
Capex/OCF
0%
SBC/OCF
—
% PPE
0,1%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
6,8%
CAGR Op. Income 5Y
-20,2%
CAGR Net Income 5Y
-7,6%
CAGR EPS 5Y
-26,8%
CAGR OCF 5Y
29%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
1,6
Quick Ratio
1,4
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!